Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001323173 | SCV001514077 | benign | Dilated cardiomyopathy 1DD | 2024-09-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002322243 | SCV002610769 | uncertain significance | Cardiovascular phenotype | 2022-11-04 | criteria provided, single submitter | clinical testing | The p.E1073K variant (also known as c.3217G>A), located in coding exon 11 of the RBM20 gene, results from a G to A substitution at nucleotide position 3217. The glutamic acid at codon 1073 is replaced by lysine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species; however, lysine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV001323173 | SCV002791911 | uncertain significance | Dilated cardiomyopathy 1DD | 2021-10-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004692499 | SCV005191031 | uncertain significance | not provided | criteria provided, single submitter | not provided |